​

Funding Round

Series A - Tessa Therapeutics

Series A - Tessa Therapeutics

Investment Firm

Overview

Tessa Therapeutics is a provider of therapy designed to focus on T cell therapy for solid tumors.

Announced Date

Jun 09, 2022

Funding Type

Series A

Highlights

Location

Asia

Social

Investor Lead

Polaris Partners

Polaris Partners

Polaris Partners is a early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorHeliconia Capital Management
Participant InvestorTemasek Holdings
Participant InvestorEDBI
Participant InvestorPolaris Partners

Round Details and Background

Tessa Therapeutics raised $126000000 on 2022-06-09 in Series A

Tessa Therapeutics is a provider of therapy designed to focus on T cell therapy for solid tumors.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 12, 2018
Venture Round - Tessa Therapeutics
-50.0M
Mar 14, 2018
Series E - Tessa Therapeutics
1-undefined
Jun 09, 2022
Series A - Tessa Therapeutics
5-126.0M
May 19, 2023
Grant - Tessa Therapeutics
1-74.4K

Recent Activity

There is no recent news or activity for this profile.